Physician profile
Grigor Grigoryan
NPI 1750726857
$6,021.04
in general payments reported to CMS, 2019-2025
17 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,081 · 2020: $20.32 · 2021: $1,342 · 2022: $696 · 2023: $929 · 2024: $740 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,360 · Travel and Lodging: $475 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.86 |
| Travel and Lodging | $475.04 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,105.63 | 2019-2023 | Oxford, Oxford Partial Knee, Tapestry |
| Empire Medical, INC | $1,213.57 | 2021 | |
| Stryker Corporation | $985.59 | 2022-2025 | Gamma, Mako, T2 Alpha |
| Ironshore Pharmaceuticals INC. | $272.60 | 2022-2024 | Jornay Pm |
| Exactech, INC. | $94.93 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $73.04 | 2024 | Exparel, Iovera, Zilretta |
| Saxum Surgical, INC. | $47.62 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $33.18 | 2025 | |
| Dynasplint Systems INC. | $31.04 | 2022-2023 | Dynasplint |
| Bioventus LLC | $26.07 | 2025 | Xcell |
| Abbott Laboratories | $24.97 | 2024 | Proclaim |
| Depuy Synthes Sales INC. | $21.30 | 2025 | Orthovisc |
| Astellas Pharma US INC | $20.32 | 2020 | |
| Bausch Health US, LLC | $19.38 | 2023 | Aplenzin |
| Livanova USA, INC. | $19.23 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $18.44 | 2023 | |
| Tris Pharma INC | $14.13 | 2025 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grigor Grigoryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.